Evidence map›Paper›PMID 40779114›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

MODIG: An Attention Mechanism-Based Approach to Cancer Driver Gene Identification.

Wenyi Zhao, Zhan Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wenyi ZhaoState Key Laboratory of Advanced Drug Delivery and Release Systems & Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Zhan ZhouState Key Laboratory of Advanced Drug Delivery and Release Systems & Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. zhanzhou@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying genes that play a causal role in carcinogenesis remains one of the major challenges in cancer biology. With the accumulation of high-throughput multi-omics data over decades, it has become a great challenge to effectively integrate these data into the identification of cancer driver genes. Here, we propose MODIG, a graph attention network (GAT)-based framework, to identify cancer driver genes by combining multi-omics pan-cancer data (mutations, copy number variants, gene expression, and methylation levels) with multidimensional gene networks. Among them, the multidimensional gene network is constructed by using genes as nodes and five types of gene associations (protein-protein interaction, gene sequence similarity, KEGG pathway co-occurrence, gene co-expression patterns, and gene ontology terms) as multiplex edges. We apply a GAT encoder to model within-dimension interactions to generate a gene representation for each dimension based on this graph, introduce a joint learning module to fuse multiple dimension-specific representations to generate general gene representations, and use the obtained gene representation to perform a semi-supervised driver gene identification task. The MODIG program is available at https://github.com/zjupgx/modig . The code and data are also available on Zenodo, at https://doi.org/10.5281/zenodo.7057241 .

Indexed as

Computational BiologyGene Regulatory NetworksNeoplasmsSoftwareAlgorithmsDatabases, GeneticDNA Copy Number VariationsDNA MethylationGene Expression Regulation, NeoplasticGenomicsHumansMutationAttention mechanismDriver geneGene networkGraph attention networkMulti-omics dataProtein-protein interaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.